Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Submitted by
admin
on August 31, 2013 - 11:58am
Source:
Street Insider
News Tags:
Teva
NUVIGIL
bipolar disorder
Headline:
Teva Final Phase III Study of Armodafinil Did Not Meet Primary Endpoints
Do Not Allow Advertisers to Use My Personal information
